Jesús-Díaz, D. D., Goldberg, A., Abella, E., Schelle, M., Crimmins, G. (2025). Phase 1, open-label, multi-center trial of RPT1G in patients with Relapsed/Refractory Acute Myeloid Leukemia and high-risk Myelodysplastic Syndromes/neoplasms. Blood. https://doi.org/10.1182/blood-2025-5208